Molecular Imaging: Page 317

PET/CT detects head/neck cancer recurrences earlier

By Cynthia E. Keen

Routine use of follow-up PET/CT scans can detect local cancer recurrences before they become clinically apparent, and may improve outcomes of subsequent salvage therapy, according to a study presented on Friday at the Multidisciplinary Head and Neck Cancer Symposium in Phoenix.

January 27, 2012

Shine Medical picks Mo-99 plant site in Wis.

By AuntMinnie.com staff writers

Medical isotope firm Shine Medical Technologies has unveiled plans to build a new molybdenum-99 (Mo-99) manufacturing plant in Janesville, WI.

January 24, 2012

Cell>Point inks Brazilian license deal

By AuntMinnie.com staff writers

Radiopharmaceutical developer Cell>Point has signed a long-term collaboration agreement including product licenses for Brazil with MJM Produtos Farmacêuticos e de Radioproteção (Radiopharmacus).

January 24, 2012

BSGI equals MRI as an adjunct in breast cancer cases

By Wayne Forrest

Researchers in Oregon have concluded that breast-specific gamma imaging (BSGI) is equivalent to MRI as an adjunct imaging modality for diagnosing breast cancer. BSGI may be particularly useful in evaluating women at high risk for cancer, or those with dense breasts.

January 24, 2012

Sofie to receive patent for PET probes

By AuntMinnie.com staff writers

Molecular imaging developer Sofie Biosciences has been told that it will receive a U.S. patent that covers a line of novel PET probes, known as F-18 FAC.

January 23, 2012

NRG gets OK for new nuclear reactor

By AuntMinnie.com staff writers

Radiopharmaceutical producer Nuclear Research and Consultancy Group (NRG) received approval from the Dutch government on January 20 to proceed with a new nuclear research reactor to replace an existing reactor in Petten.

January 22, 2012